2021
Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy
Raju SC, Peters GW, Decker RH, Park HS. Clinical Outcomes and Safety Profile in the Treatment of Synchronous Nonmetastatic Lung Tumors With Stereotactic Body Radiation Therapy. Practical Radiation Oncology 2021, 12: e110-e116. PMID: 34861443, DOI: 10.1016/j.prro.2021.11.006.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyPrimary lung tumorsSynchronous primary lung tumorsAdverse events gradeCommon Terminology CriteriaBody radiation therapyLung tumorsNew primaryTerminology CriteriaOverall survivalClinical outcomesLung cancerRadiation therapyEvents gradeEarly-stage primary lung cancerMedian progression-free survivalEffective doseDistant failure ratesLocal failure rateMedian overall survivalMedian total dosePrimary lung cancerProgression-free survivalPatterns of recurrenceNonmetastatic lung cancer
2015
Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy
Harder EM, Park HS, Nath SK, Mancini BR, Decker RH. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy. Practical Radiation Oncology 2015, 5: e643-e649. PMID: 26412341, DOI: 10.1016/j.prro.2015.07.003.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyACE inhibitor useNonsteroidal anti-inflammatory drugsAngiotensin receptor blockersRadiation pneumonitisSymptomatic radiation pneumonitisInhibitor useBody radiation therapyAnti-inflammatory drugsRadiation therapyReceptor blockersACE inhibitorsAngiotensin-converting enzyme inhibitor useACE inhibitor usersCommon Terminology CriteriaEnzyme inhibitor usePrimary lung cancerNormal lung tissuesAvailable medical recordsCox proportional hazardsPulmonary doseTerminology CriteriaInhibitor usersAdverse eventsOverall survival
2013
Lethality of Cardiovascular Events Highlights the Variable Impact of Complication Type Between Thoracoscopic and Open Pulmonary Lobectomies
Law TD, Boffa DJ, Detterbeck FC, Wang Z, Park HS, Kim AW. Lethality of Cardiovascular Events Highlights the Variable Impact of Complication Type Between Thoracoscopic and Open Pulmonary Lobectomies. The Annals Of Thoracic Surgery 2013, 97: 993-999. PMID: 24370204, DOI: 10.1016/j.athoracsur.2013.10.026.Peer-Reviewed Original ResearchConceptsOpen cohortNumber of complicationsVATS cohortComplication typePulmonary lobectomyUtilization Project Nationwide Inpatient Sample databaseNationwide Inpatient Sample databaseICD-9-CM codesOpen pulmonary lobectomyOpen thoracotomy approachPrimary lung malignancyPrimary lung cancerClinical Modification codesLogistic regression modelingGastrointestinal complicationsCardiovascular complicationsCardiovascular eventsPerioperative complicationsPerioperative mortalityPostoperative complicationsThoracotomy approachLung malignancyOpen lobectomyVATS lobectomyLung cancer
2011
Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes
Park HS, Detterbeck FC, Boffa DJ, Kim AW. Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes. The Annals Of Thoracic Surgery 2011, 93: 372-379. PMID: 21945225, DOI: 10.1016/j.athoracsur.2011.06.054.Peer-Reviewed Original ResearchConceptsPrimary lung cancer patientsLung cancer patientsShorter LOSMultivariable analysisMedian LOSHospital volumeIndependent predictorsPulmonary lobectomyOpen lobectomyCancer patientsVAT volumeUtilization Project Nationwide Inpatient Sample databaseVideo-assisted thoracoscopic surgery lobectomyHospital operative volumeShorter median LOSLung cancer outcomesPrimary lung cancerHigher hospital volumeShort-term outcomesThoracoscopic surgery lobectomyDiseases procedure codesTotal complicationsHospital lengthHospital morbidityVATS patients